Atossa Genetics (ATOS) Misses Q2 EPS by 2c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• GTA VI to catalyze a multi-year improvement in earnings power for TTWO, BTIG says
• BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'